NCT02176967: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- State
- Under way
- Phase
- Phase 3
- People
- 391 taking part
- Started
- 8 Aug 2014
- Primary completion
- 30 Sep 2026
- Arms
- Group A (clinical observation)
- Results
- None posted
- 27 Jun 2014: Trial registered
- 8 Aug 2014: Trial started